VIBONATE 60ARTESUNATE 60mg. IP

Vibonate 60 is an artesunate 60 mg injection used for severe malaria treatment. Main uses: treatment of severe malaria caused by Plasmodium falciparum; treatment of severe malaria caused by other Plasmodium species; parenteral treatment of severe malaria when tablets cannot be given; reduction of parasite count in serious malaria infection.

Common side effects of Vibonate 60 Injection include nausea; vomiting; dizziness; headache; abdominal discomfort; pain or swelling at the injection site. Get medical help at once if you notice delayed haemolytic anaemia after treatment; severe allergic reaction including rash, swelling or breathing difficulty; low neutrophil count.

Vibonate 60 Injection contains Artesunate 60 mg. Vibonate 60 Injection is given by a doctor or nurse, who decides the dose and how often it is given.

The MRP of Vibonate 60 Injection is ₹180 for a pack of 1. For chemists and distributors, the PTR is ₹137.14 and the PTS is ₹123.43.

Vibonate 60 Injection contains Artesunate 60 mg. It comes in a pack of 1.

Artesunate works by an artemisinin-based action. Once it enters the body it is changed into dihydroartemisinin, which acts on the blood stages of the malaria parasite, including Plasmodium falciparum. By attacking the parasite at this stage, it helps to bring down the parasite count in the blood and supports the management of a serious malaria infection.

Must not be used in patients allergic to artesunate or any artemisinin derivative. Check with a doctor first in pregnancy. Check with a doctor first in liver or kidney disease. Check with a doctor first in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Must only be given by a doctor or trained nurse.

Vibonate 60 Injection is a brand of Vibcare Pharma, sold through its Genvimax division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.